Biology Reference
In-Depth Information
180. Moens AL, Kietadisorn R, Lin JY, Kass D
(2011) Targeting endothelial and myocardial
dysfunction with tetrahydrobiopterin. J Mol
Cell Cardiol 51:559-563
181. Forstermann U, Sessa WC (2011) Nitric
oxide synthases: regulation and function. Eur
Heart J 33:829-837
182. Karbach S, Simon A, Slenzka A, Jaenecke I,
Habermeier A, Martine U, Forstermann U,
Closs EI (2011) Relative contribution of dif-
ferent L -arginine sources to the substrate sup-
ply of endothelial nitric oxide synthase. J Mol
Cell Cardiol 51:855-861
183. Pacher P, Beckman JS, Liaudet L (2007)
Nitric oxide and peroxynitrite in health and
disease. Physiol Rev 87:315-424
184. Otani H (2009) The role of nitric oxide in
myocardial repair and remodeling. Antioxid
Redox Signal 11:1913-1928
185. Hein TW, Zhang C, Wang W, Chang CI,
Thengchaisri N, Kuo L (2003) Ischemia-
reperfusion selectively impairs nitric oxide-
mediated dilation in coronary arterioles:
counteracting role of arginase. FASEB J
17:2328-2330
186. Dweik RA (2005) Nitric oxide, hypoxia, and
superoxide: the good, the bad, and the ugly!
Thorax 60:265-267
187. Ryou MG, Flaherty DC, Hoxha B, Sun J,
Gurji H, Rodriguez S, Bell G, Olivencia-
Yurvati AH, Mallet RT (2009) Pyruvate-
fortified cardioplegia evokes myocardial
erythropoietin signaling in swine undergoing
cardiopulmonary bypass. Am J Physiol Heart
Circ Physiol 297:H1914-H1922
188. Allegra V, Mengozzi G, Martimbianco L,
Vasile A (1996) Early and late effects of eryth-
ropoietin on glucose metabolism in mainte-
nance hemodialysis patients. Am J Nephrol
16:304-308
189. Mak RH (1996) Correction of anemia by
erythropoietin reverses insulin resistance and
hyperinsulinemia in uremia. Am J Physiol
270:F839-F844
190. Tuzcu A, Bahceci M, Yilmaz E, Bahceci S,
Tuzcu S (2004) The comparison of insulin
sensitivity in non-diabetic hemodialysis
patients treated with and without recombi-
nant human erythropoietin. Horm Metab
Res 36:716-720
191. Fenjves ES, Ochoa MS, Gay-Rabinstein C,
Molano RD, Pileggi A, Mendez AJ, Inverardi
L, Ricordi C (2004) Adenoviral gene transfer
of erythropoietin confers cytoprotection to
isolated pancreatic islets. Transplantation
77:13-18
192. Katz O, Stuible M, Golishevski N, Lifshitz L,
Tremblay ML, Gassmann M, Mittelman M,
Neumann D (2010) Erythropoietin treatment
leads to reduced blood glucose levels and
body mass: insights from murine models.
J Endocrinol 205:87-95
193. Shuai H, Zhang J, Xie J, Zhang M, Yu Y,
Zhang L (2011) Erythropoietin protects pan-
creatic beta-cell line NIT-1 cells against
cytokine-induced apoptosis via phosphati-
dylinositol 3-kinase/Akt signaling. Endocr
Res 36:25-34
194. Choi D, Schroer SA, Lu SY, Wang L, Wu X,
Liu Y, Zhang Y, Gaisano HY, Wagner KU,
Wu H, Retnakaran R, Woo M (2010)
Erythropoietin protects against diabetes
through direct effects on pancreatic beta cells.
J Exp Med 207:2831-2842
195. Scully MS, Ort TA, James IE, Bugelski PJ,
Makropoulos DA, Deutsch HA, Pieterman
EJ, van den Hoek AM, Havekes LM, Dubell
WH, Wertheimer JD, Picha KM (2011) A
novel EPO receptor agonist improves glucose
tolerance via glucose uptake in skeletal muscle
in a mouse model of diabetes. Exp Diabetes
Res 2011:910159
196. Noguchi CT, Wang L, Rogers HM, Teng R,
Jia Y (2008) Survival and proliferative roles of
erythropoietin beyond the erythroid lineage.
Expert Rev Mol Med 10:e36
197. Masuda H, Asahara T (2003) Post-natal
endothelial progenitor cells for neovascular-
ization in tissue regeneration. Cardiovasc Res
58:390-398
198. Urbich C, Dimmeler S (2004) Endothelial
progenitor cells: characterization and role in
vascular biology. Circ Res 95:343-353
199. Carlini RG, Alonzo EJ, Dominguez J, Blanca
I, Weisinger JR, Rothstein M, Bellorin-Font
E (1999) Effect of recombinant human eryth-
ropoietin on endothelial cell apoptosis. Kidney
Int 55:546-553
200. Carlini RG, Reyes AA, Rothstein M (1995)
Recombinant human erythropoietin stimu-
lates angiogenesis in vitro. Kidney Int
47:740-745
201. Ribatti D, Presta M, Vacca A, Ria R, Giuliani
R, Dell'Era P, Nico B, Roncali L, Dammacco
F (1999) Human erythropoietin induces a
pro-angiogenic phenotype in cultured
endothelial cells and stimulates neovascular-
ization in vivo. Blood 93:2627-2636
202. Bahlmann FH, DeGroot K, Duckert T,
Niemczyk E, Bahlmann E, Boehm SM, Haller
H, Fliser D (2003) Endothelial progenitor
cell proliferation and differentiation is regu-
lated by erythropoietin. Kidney Int
64:1648-1652
203. Bahlmann FH, De Groot K, Spandau JM,
Landry AL, Hertel B, Duckert T, Boehm SM,
Search WWH ::




Custom Search